AI People Wiki

Builders & open source

Kimberly Powell

VP/GM, Healthcare, NVIDIA

Kimberly Powell is vice president of healthcare at NVIDIA, listed as VP/GM, Healthcare among the GTC Berlin 2026 speakers, and is responsible for the company's worldwide healthcare business across medical imaging, life sciences, drug discovery and healthcare analytics. Powell joined NVIDIA in 2008 to establish NVIDIA GPUs as the accelerator platform for medical imaging instruments, and later led the company's higher education and research business, strategic evangelism programs, NVIDIA AI Labs and the NVIDIA Inception program. Powell's NVIDIA blog posts include a November 2023 announcement of NVIDIA BioNeMo for generative AI drug discovery on AWS and a January 2025 post on building agentic AI for healthcare and life sciences with IQVIA.12

At a glance

Current role
VP/GM, Healthcare
Company
NVIDIA
Sector
Company
Work listed
1
Sources cited
2
Profile reviewed

Career

Powell joined NVIDIA in 2008 with responsibility for establishing NVIDIA GPUs as the accelerator platform for medical imaging instruments. Powell later led the company's higher education and research business, along with its strategic evangelism programs, NVIDIA AI Labs and the NVIDIA Inception program for start-ups.1

As vice president of healthcare, Powell is responsible for NVIDIA's worldwide healthcare business, covering hardware and software platforms for accelerated computing, AI and visualization used in medical imaging, life sciences, drug discovery and healthcare analytics. At GTC Berlin in October 2026, Powell was listed as VP/GM, Healthcare, and as the speaker for the talk "Turning AI Into the Infrastructure Advancing Human Health".12

Writing

Powell's posts on NVIDIA's blog track the company's healthcare platforms. They include a 2021 announcement of an AI computing platform for real-time sensing in medical instruments and devices, a 2022 post on a fast DNA sequencing technique for critical-care diagnosis, the 2023 arrival of NVIDIA BioNeMo and Clara services on AWS, and a 2024 essay on generative AI and digital biology in drug discovery.1

Later posts covered healthcare and biomedical computing projects in Japan and Taiwan in 2024 and, in January 2025, NVIDIA's work with IQVIA on custom foundation models and agentic AI workflows for healthcare and life sciences.1

Work and contributions

  • NVIDIA healthcare platforms (Clara and BioNeMo)

    Responsible for NVIDIA's healthcare hardware and software platforms for accelerated computing, AI and visualization; wrote NVIDIA's November 2023 post on deploying NVIDIA BioNeMo and Clara on AWS and its January 2024 post on generative AI for drug discovery and design.1

Timeline

  1. Joined NVIDIA to establish its GPUs as the accelerator platform for medical imaging instruments.1
  2. Announced an NVIDIA AI computing platform for real-time sensing in medical instruments and devices.1
  3. Wrote about a DNA sequencing technique that helps clinicians rapidly diagnose critical-care patients.1
  4. Announced NVIDIA BioNeMo for generative AI drug discovery on Amazon Web Services.1
  5. Wrote on how generative AI is opening a new era of drug discovery and design.1
  6. Announced NVIDIA and IQVIA's work on domain-expert agentic AI for healthcare and life sciences.1
  7. Listed as the speaker for the GTC Berlin talk "Turning AI Into the Infrastructure Advancing Human Health".2

Where they work

Suggest a correction or removal

Profiles cover public professional work only, and each statement cites a source. If something is out of date, missing or wrong, tell us and link a source. People can also ask for their profile to be corrected or removed.

References

2 sources · profile reviewed Oct 21, 2026 · data updated Oct 21, 2026

  1. Kimberly Powell — NVIDIA Blog author pageNVIDIA · Official page · accessed Oct 21, 2026
  2. GTC Berlin AI Conference, 20–22 October 2026 (speakers and sessions)NVIDIA · Official page · accessed Oct 21, 2026